drugset
Drugs / Sodium chenodeoxycholate
last change Aug 2010 re-read 3 minutes ago

Sodium chenodeoxycholate

also known as NaCDC
Developed for
irritable bowel syndrome
Investigated by
Mayo Clinic · National Center for Research Resources (NCRR) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Trials 1

today NCT00912301 · Ph 2
2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00912301 Apr → Nov 2009 irritable bowel syndrome Mayo Clinic Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Sodium chenodeoxycholate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00912301 ↗
Known as NaCDC “Sodium chenodeoxycholate (NaCDC)” NCT00912301 ↗
Route Oral “delayed-release oral formulations of placebo, 500 mg CDC, or 1000 mg CDC for 4 days” PMID 20691689 ↗ Aug 2010